Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 235 citing articles:

COVID-19 and comorbidities: Deleterious impact on infected patients
Hasan Ejaz, Abdullah Alsrhani, Aizza Zafar, et al.
Journal of Infection and Public Health (2020) Vol. 13, Iss. 12, pp. 1833-1839
Open Access | Times Cited: 931
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
Awadhesh Kumar Singh, Ritesh Gupta, Amerta Ghosh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 4, pp. 303-310
Open Access | Times Cited: 894
COVID-19 pandemic, coronaviruses, and diabetes mellitus
Ranganath Muniyappa, Sriram Gubbi
AJP Endocrinology and Metabolism (2020) Vol. 318, Iss. 5, pp. E736-E741
Open Access | Times Cited: 859
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Marcin F. Osuchowski, Martin Sebastian Winkler, Tomasz Skirecki, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 6, pp. 622-642
Open Access | Times Cited: 475
Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide
Fabián Sanchis‐Gomar, Carl J. Lavie, Mandeep R. Mehra, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 7, pp. 1445-1453
Open Access | Times Cited: 353
On the whereabouts of SARS-CoV-2 in the human body: A systematic review
Wim Trypsteen, Jolien Van Cleemput, Willem van Snippenberg, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 10, pp. e1009037-e1009037
Open Access | Times Cited: 212
SARS-CoV-2, ACE2 expression, and systemic organ invasion
Usman Ashraf, Ahmed A. Abokor, Jonnelle M. Edwards, et al.
Physiological Genomics (2020) Vol. 53, Iss. 2, pp. 51-60
Open Access | Times Cited: 151
The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review
Philip James, Zakari Ali, Andrew E. Armitage, et al.
Journal of Nutrition (2021) Vol. 151, Iss. 7, pp. 1854-1878
Open Access | Times Cited: 128
Protective Effect of Vitamin D Supplementation on COVID-19-Related Intensive Care Hospitalization and Mortality: Definitive Evidence from Meta-Analysis and Trial Sequential Analysis
Christiano Argano, Raffaella Mallaci Bocchio, Giuseppe Natoli, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 130-130
Open Access | Times Cited: 59
Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
Katherine Mackey, Valerie King, Susan B. Gurley, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 3, pp. 195-203
Open Access | Times Cited: 126
Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19
Jacqueline A. Seiglie, Jesse M. Platt, Sara J. Cromer, et al.
Diabetes Care (2020) Vol. 43, Iss. 12, pp. 2938-2944
Open Access | Times Cited: 120
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study
Vito Lampasona, Massimiliano Secchi, Marina Scavini, et al.
Diabetologia (2020) Vol. 63, Iss. 12, pp. 2548-2558
Open Access | Times Cited: 111
Impact of Diabetes in Patients Diagnosed With COVID-19
Mohamed Abu‐Farha, Fahd Al‐Mulla, Thangavel Alphonse Thanaraj, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 106
Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients
Begum Dariya, Ganji Purnachandra Nagaraju
Cytokine & Growth Factor Reviews (2020) Vol. 53, pp. 43-52
Open Access | Times Cited: 101
COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports
Matthew C. Riddle, John B. Buse, Paul W. Franks, et al.
Diabetes Care (2020) Vol. 43, Iss. 7, pp. 1378-1381
Open Access | Times Cited: 95
COVID-19 and diabetes mellitus: how one pandemic worsens the other
William S. Azar, Rachel Njeim, Angie H Fares, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 21, Iss. 4, pp. 451-463
Open Access | Times Cited: 93
Physical activity and COVID-19. The basis for an efficient intervention in times of COVID-19 pandemic
Vicente Javier Clemente‐Suárez, Ana Isabel Beltrán-Velasco, Domingo Jesús Ramos‐Campo, et al.
Physiology & Behavior (2021) Vol. 244, pp. 113667-113667
Open Access | Times Cited: 92
SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets
V. Jayalakshmi, Albin John, Willayat Yousuf Wani, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 10, pp. 165889-165889
Open Access | Times Cited: 91
Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
Salvatore Corrao, Karen Pinelli, Martina Vacca, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 91
Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity
Gabriel Pasquarelli-do-Nascimento, Heloísa Antoniella Braz-de-Melo, Sara Socorro Faria, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 90
Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral–bacterial interactions
Ilja L. Kruglikov, Manasi Shah, Philipp E. Scherer
eLife (2020) Vol. 9
Open Access | Times Cited: 89
Diabetes and COVID-19: The past, the present, and the future
Raymond Pranata, Joshua Henrina, Wilson Matthew Raffaello, et al.
Metabolism (2021) Vol. 121, pp. 154814-154814
Open Access | Times Cited: 86
Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next
Angeliki M. Angelidi, Matthew J. Belanger, Christos S. Mantzoros
Metabolism (2020) Vol. 107, pp. 154245-154245
Open Access | Times Cited: 83
SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease
Rajasree Menon, Edgar A. Otto, Rachel Sealfon, et al.
Kidney International (2020) Vol. 98, Iss. 6, pp. 1502-1518
Open Access | Times Cited: 77
Coronavirus and Obesity: Could Insulin Resistance Mediate the Severity of Covid-19 Infection?
Francis Finucane, Colin Davenport
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 71
Page 1 - Next Page

Scroll to top